Venable partner Todd Harrison presented “Cannabis, Hemp, and the Legal Status of Products Containing Cannabidiol (CBD)” at the Controlled Substances – Regulation, Litigation, and Enforcement conference hosted by ACI on July 22, 2020. Topics included:
- Analyzing the recent scheduling change of CBD in the wake of the DEA’s schedule I classification of the epilepsy medication Epidiolex
- Reviewing the status of hemp, marijuana, and other cannabinoids under current federal law
- Distinguishing “hemp-derived” from “marijuana-derived”
- Navigating the legal pathways for bringing cannabinoids to market
- Considering the evolving development of state cannabis laws
- Understanding the emergence of cannabidiol and its future in the controlled substance arena
- Complying with state storage and record-keeping laws
© 2020 Venable LLP. Using, distributing, possessing, and/or selling marijuana is illegal under existing federal law. Compliance with state law does not guarantee or constitute compliance with federal law. This informational overview is not intended to provide any legal advice or any guidance or assistance in violating federal law